Experimental Research on Deep Carious Lesion Treatment of Molars (NCT03626740) | Clinical Trial Compass
CompletedNot Applicable
Experimental Research on Deep Carious Lesion Treatment of Molars
Romania40 participantsStarted 2018-01-08
Plain-language summary
Maintaining dental pulp vitality is crucial for tooth preservation and functionality. Untreated dental caries may lead to pulp necrosis and infection, affecting children's growth and well-being. The first permanent teeth erupt around 6 years old. These are the first molars (FPM), which are frequently affected by caries, soon after their eruption.
In the present application, our main goal is to determine whether two treatment groups (MTA and TheraCal) are long-term effective in preserving pulp vitality among children' FPM affected by deep caries.
Who can participate
Age range
6 Years – 12 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* untreated deep uncomplicated carious lesions in first permanent molars (FPM)
* absence of clinical diagnosis of pulp exposure
* fistula
* swelling of periodontal tissues
* abnormal tooth mobility
* history of spontaneous pain or sensitivity to percussion
* healthy appearance of adjacent gingiva
* normal tooth color
* positive vitality to thermal and electric tests.
Exclusion Criteria:
* FPM with previous treatment
* FPM with developmental abnormalities (such as enamel hypoplasia, dentinogenesis imperfecta etc.)
* children with mental disabilities or systemic diseases.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Clinical pulpal survival rate
Timeframe: 20 months
Trial details
NCT IDNCT03626740
SponsorCarol Davila University of Medicine and Pharmacy